Adcendo Aps
Clinical trials sponsored by Adcendo Aps, explained in plain language.
-
New hope for sarcoma: targeted drug ADCE-D01 enters human trials
Disease control Recruiting nowThis study tests a new drug, ADCE-D01, for people with soft tissue sarcoma that has spread or cannot be removed by surgery. The drug is designed to find and attack cancer cells while leaving healthy cells alone. About 270 adults will take part to see if the drug is safe and works…
Phase: PHASE1, PHASE2 • Sponsor: Adcendo ApS • Aim: Disease control
Last updated May 17, 2026 02:26 UTC
-
New drug ADCE-B05 targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis early-phase study tests a new drug called ADCE-B05 in people with advanced solid tumors that have not responded to other treatments. The main goals are to find the safest dose and to check for side effects. About 180 adults will take part, and the drug is given alone at diff…
Phase: PHASE1 • Sponsor: Adcendo ApS • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called ADCE-T02 in people with advanced solid tumors that have not responded to other treatments. The drug is designed to target and attack cancer cells while sparing healthy ones. The main goals are to find the safest dose and understand s…
Phase: PHASE1 • Sponsor: Adcendo ApS • Aim: Disease control
Last updated May 11, 2026 20:41 UTC